south congress semaglutide weight loss Can new drugs live up to the hype? The Pros and Cons of

Novo Nordisks semaglutide and Eli Lillys tirzepatideboth leading GLP-1 agonists used for weight loss and diabetesare associated with a lowered likelihood of developing neurodegenerative disorders such as dementia, according to a recent study

Treatment of diabetes and diabetic complications with a ketogenic diet

Some weight loss supplements, like Lemme, have capitalized on the success of these drugs and, although they may have GLP-1 in their names, they are not the same as the prescription medications containing semaglutide

There have been few trials on the use of antiemetics such as ondansetron and aprepitant in people with severe gastroparesis

Although competition and innovation are likely to bring the costs of the drugs down, especially as generic versions become available (many years in the future), the drugs are phenomenally expensive (commonly between 75-300 privately in the UK)